Abstract: A method for calculating carbon credits includes obtaining sensor data associated with at least a portion of a deployment for cultivating a target product in a body of water, executing at least one model based at least in part on the sensor data to generate an output predicting at least one characteristic associated with the target product, the deployment, or a portion of the body of water, and inputting the output into a quantification model. The quantification model is executed to generate an output associated with a predicted capacity of the target product to sequester carbon dioxide. An accuracy of the predicted capacity resulting from the output of the quantification model is greater than an accuracy of a predicted or inferred capacity resulting from the output of each model individually. Carbon dioxide offset credits are determined based on the predicted capacity resulting from the output of the quantification model.

Abstract: The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R2, R4, & R5, are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating neurological conditions.

Abstract: The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R2, R4, & R5, are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating neurological conditions.

Abstract: The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R2, R4, & R5, are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating neurological conditions.

Abstract: Disclosed are compounds that can serve as melatonin analogue prodrugs and that are soluble in aqueous solvents. Melatonin or melatonin analogues having modifications to the indole moiety are coupled to a tertiary amine to form a quaternary amine such that there is a saturated two-carbon linkage between the carbonyl of the melatonin structure and the amine nitrogen. This structure is stable in acidic environments, but is unstable at basic or neutral pH. Therefore, these melatonin analogue prodrugs are stable in a vial at acidic pH, but will breakdown upon injection into the body to liberate the melatonin analogue and the tertiary amine, which is nontoxic. The melatonin analogue being not modified on the indole moiety exerts similar pharmacological properties as melatonin: antioxidation, sedation and anesthesia.

Abstract: The present invention relates to flexible electrode material, preferably lead chloride, and to a method and apparatus for the continuous manufacture thereof. Such electrode material is useful in sea water batteries for sonobuoys.